80 FR 178 pgs. 55362-55364 - Proposed Data Collection Submitted for Public Comment and Recommendations
Type: NOTICEVolume: 80Number: 178Pages: 55362 - 55364
Pages: 55362, 55363, 55364Docket number: [60Day-15-15BEZ; Docket No. CDC-2015-0081]
FR document: [FR Doc. 2015-23088 Filed 9-14-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-15BEZ; Docket No. CDC-2015-0081]
Proposed Data Collection Submitted for Public Comment and Recommendations
AGENCY:
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice with comment period.
SUMMARY:
The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a newly proposed information collection request entitled Improving Fetal Alcohol Spectrum Disorders Prevention Practice through Practice and Implementation Centers and National Partnerships.
DATES:
Written comments must be received on or before November 16, 2015.
ADDRESSES:
You may submit comments, identified by Docket No. CDC-2015-0081 by any of the following methods:
• Federal eRulemaking Portal: Regulation.gov. Follow the instructions for submitting comments.
• Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov , including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov .
Please note:
All public comment should be submitted through the Federal eRulemaking portal ( Regulations.gov ) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT:
To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information.
Proposed Project
[top] Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through Practice and Implementation Centers and National Partnerships-New-National Center on Birth Defects and Developmental Disabilities
Background and Brief Description
The National Center on Birth Defects and Developmental Disabilities seeks to collect training evaluation data from healthcare practitioners and staff in health systems where FASD-related practice and systems changes are implemented, and grantees of Practice and Implementation Centers and national partner organizations related to prevention, identification, and treatment of fetal alcohol spectrum disorders (FASDs).
Prenatal exposure to alcohol is a leading preventable cause of birth defects and developmental disabilities. The term "fetal alcohol spectrum disorders" describes the full continuum of effects that can occur in an individual exposed to alcohol in utero. These effects include physical, mental, behavioral, and learning disabilities. All of these have lifelong implications.
The purpose of this program is to expand previous efforts from FASD training programs and shift the perspective from individual training for practicing health care professionals to one that capitalizes on prevention opportunities and the ability to impact health care practice at the systems level.
Since 2002, CDC funded FASD Regional Training Centers (RTCs) to provide education and training to healthcare professionals and students about FASD prevention, identification, and treatment. In July 2013, CDC convened an expert review panel to evaluate the effectiveness of the RTC program overall and make recommendations about the program. The panel highlighted several accomplishments of the RTCs and proposed several changes for future programming: (1) The panel identified a need for more comprehensive coverage nationally with discipline-specific trainings, increased use of technology, greater collaboration with medical societies, and stronger linkages with national partner organizations to increase the reach of training opportunities, and (2) The panel suggested that the training centers focus on demonstrable practice change and sustainability and place a stronger emphasis on primary prevention of FASDs. In addition, it was recommended that future initiatives have stronger evaluation components.
Based on the recommendations of the expert review panel, CDC is placing increased focus on prevention, demonstrating practice change, achieving national coverage, and strengthening partnerships between FASD Practice and Implementation Centers, or PICs (the newly redesigned RTCs), and medical societies and national partner organizations. The National Organization on Fetal Alcohol Syndrome (NOFAS) also participates in this project as a resource to the PICS and national partners. The PICs and national partners are asked to closely collaborate in discipline-specific workgroups (DSWs) and identify strategies that will increase the reach of the program on a national level. While a major focus of the grantees' work will be national, regional approaches will be used to develop new content and "test out" feasibility and acceptability of materials, especially among health care providers and medical societies. In addition, CDC is placing a stronger emphasis on evaluation, with both individual DSW/NOFAS evaluations and a cross-site evaluation.
CDC requests OMB approval to collect program evaluation information from (1) healthcare practitioners from disciplines targeted by each DSW, including training participants, (2) health system staff, and (3) cooperative agreement grantees over a three-year period.
• Healthcare practitioners will complete surveys to provide information on whether project trainings impacted their knowledge and practice behavior regarding FASD identification, prevention, and treatment. The information will be used to improve future trainings and assess whether knowledge and practice changes occurred. Some participants will also complete qualitative key informant interviews to gain additional information on practice change.
• Health system employees will be interviewed as part of high impact evaluation studies. The high impact evaluation studies will be focused assessments of two to three specific grantee efforts that seem likely to result in achievement of program objectives.
• Grantees will complete program evaluation forms to track perceptions of DSW collaboration and perceptions of key successes and challenges encountered by the DSW.
It is estimated that 20,554 respondents will participate in the evaluation each year, for a total estimated burden of 4528.0 hours annually. There are no costs to respondents other than their time.
[top]
| Type of respondents | DSW/ Organization | Form name | Number of respondents | Number of responses per respondent | Average burden per response (in hours) | Total burden hours |
|---|---|---|---|---|---|---|
| FASD Core Training Participants | All | FASD Core Training Survey-Pre-Test | 4,013 | 1 | 15/60 | 1,003 |
| FASD Core Training Participants | All | FASD Core Training Survey-Post-Test | 4,013 | 1 | 15/60 | 1,003 |
| FASD Core Training Participants | All | FASD Core Training Survey-6 Month Follow-Up | 4,013 | 1 | 20/60 | 1,338 |
| Project Grantee Staff | Westat (Cross-Site Evaluator) | DSW Report | 90 | 2 | 10/60 | 30 |
| Project Grantee Staff | Westat (Cross-Site Evaluator) | Key Informant Interview-DSW Project Director | 6 | 3 | 60/60 | 18 |
| National Partner Staff | Westat (Cross-Site Evaluator) | Key Informant Interview-National Partner | 6 | 3 | 60/60 | 18 |
| Health System Staff | Westat (Cross-Site Evaluator) | Key Informant Interview-Health System Staff | 60 | 3 | 30/60 | 90 |
| Nurses | Nursing | Key Informant Interviews with Champions | 14 | 1 | 45/60 | 10 |
| Nurses | Nursing | Online Survey with "Friends"/Members of the Network | 34 | 2 | 15/60 | 17 |
| Healthcare Organization Representatives | Nursing | Online Survey with Healthcare Organization Representatives | 67 | 1 | 30/60 | 33 |
| Nurses and Nursing Students | Nursing | Brief Online Questionnaire for Nursing Organization Memberships | 2,934 | 1 | 10/60 | 489 |
| Physicians and students in allied health professions | Obstetrics & Gynecology | Avatar Training Satisfaction Survey | 1,200 | 1 | 6/60 | 120 |
| Students in allied health professions | Obstetrics & Gynecology | Proficiency Ratings Scale-Standardized Patient Version | 600 | 1 | 6/60 | 60 |
| Physicians | Obstetrics & Gynecology | Proficiency Ratings Scale-Provider-Baseline | 600 | 1 | 6/60 | 60 |
| Physicians | Obstetrics & Gynecology | Proficiency Rating Scale-Provider-1 Month Follow-Up | 600 | 1 | 2/60 | 20 |
| Physicians | Obstetrics & Gynecology | FASD Training Event Evaluation | 124 | 1 | 2/60 | 4 |
| Residency Directors, Training Coordinators, Clinic Directors | Obstetrics & Gynecology | Pre- Assessment of Training Implementation | 14 | 1 | 30/60 | 7 |
| Residency Directors, Training Coordinators, Clinical Directors, Physicians | Obstetrics & Gynecology | Post-Assessment of Training Implementation | 14 | 1 | 30/60 | 7 |
| Physicians | Pediatrics | FASD Core Training Survey-Pediatrics 3 Month Follow-Up | 120 | 1 | 15/60 | 30 |
| Physicians | Pediatrics | Pediatrics DSW Baseline Survey | 535 | 1 | 4/60 | 36 |
| Physicians | Pediatrics | Pediatrics DSW Year 4 Survey | 535 | 1 | 4/60 | 36 |
| Physicians | Pediatrics | FASD Toolkit User Survey | 50 | 1 | 15/60 | 13 |
| Physicians | Social Work & Family Physicians | Family Medicine Comprehensive Practice Evaluation | 62 | 1 | 8/60 | 8 |
| Medical and allied health professionals | National Organization on Fetal Alcohol Syndrome | NOFAS Webinar Survey-Post-Test | 400 | 1 | 5/60 | 33 |
| Medical and allied health professionals | National Organization on Fetal Alcohol Syndrome | NOFAS Webinar Survey-3 Month Follow-Up | 400 | 1 | 5/60 | 33 |
| General public | National Organization on Fetal Alcohol Syndrome | NOFAS Outcomes Vignette | 50 | 1 | 10/60 | 8 |
| TOTAL | 4,524 |
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-23088 Filed 9-14-15; 8:45 am]
BILLING CODE 4163-18-P